| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 501 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 368 | 2021 |
| Coronavirus disease 2019 in patients with inborn errors of immunity: an international study I Meyts, G Bucciol, I Quinti, B Neven, A Fischer, E Seoane, ... Journal of Allergy and Clinical Immunology 147 (2), 520-531, 2021 | 354 | 2021 |
| DOCK8 deficiency: clinical and immunological phenotype and treatment options-a review of 136 patients SE Aydin, SS Kilic, C Aytekin, A Kumar, O Porras, L Kainulainen, ... Journal of clinical immunology 35, 189-198, 2015 | 308 | 2015 |
| Patient‐centred screening for primary immunodeficiency, a multi‐stage diagnostic protocol designed for non‐immunologists: 2011 update E de Vries Clinical & Experimental Immunology, 2012 | 193 | 2012 |
| The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis SFN Bode, S Ammann, W Al-Herz, M Bataneant, CC Dvorak, S Gehring, ... Haematologica 100 (7), 978, 2015 | 183 | 2015 |
| The European internet‐based patient and research database for primary immunodeficiencies: update 2011 B Gathmann, N Binder, S Ehl, G Kindle Clinical & Experimental Immunology 167 (3), 479-491, 2012 | 168 | 2012 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 150 | 2022 |
| Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation MT de la Morena, D Leonard, TR Torgerson, O Cabral-Marques, M Slatter, ... Journal of Allergy and Clinical Immunology 139 (4), 1282-1292, 2017 | 134 | 2017 |
| Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations T Lorenzini, M Fliegauf, N Klammer, N Frede, M Proietti, A Bulashevska, ... Journal of Allergy and Clinical Immunology 146 (4), 901-911, 2020 | 107 | 2020 |
| Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations J Thalhammer, G Kindle, A Nieters, S Rusch, MRJ Seppänen, A Fischer, ... Journal of Allergy and Clinical Immunology 148 (5), 1332-1341. e5, 2021 | 102 | 2021 |
| Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders J Slack, MH Albert, D Balashov, BH Belohradsky, A Bertaina, J Bleesing, ... Journal of Allergy and Clinical Immunology 141 (1), 322-328. e10, 2018 | 96 | 2018 |
| Prospective neonatal screening for severe T‐and B‐lymphocyte deficiencies in Seville B de Felipe, P Olbrich, JM Lucenas, C Delgado‐Pecellin, ... Pediatric Allergy and Immunology 27 (1), 70-77, 2016 | 95 | 2016 |
| Immunoglobulin Deficiencies: The B-Lymphocyte Side of DiGeorge Syndrome K Patel, J Akhter, L Kobrynski, B Gathman, O Davis, KE Sullivan The Journal of Pediatrics, 2012 | 87 | 2012 |
| Primary and secondary immunodeficiency diseases in oncohaematology: warning signs, diagnosis, and management S Sánchez-Ramón, A Bermúdez, LI González-Granado, ... Frontiers in immunology 10, 586, 2019 | 78 | 2019 |
| Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases A Mensa-Vilaró, MB García-Morato, O de la Calle-Martin, ... Journal of Allergy and Clinical Immunology 143 (1), 359-368, 2019 | 72 | 2019 |
| Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients GK Wong, S Goldacker, C Winterhalter, B Grimbacher, H Chapel, M Lucas, ... Clinical & Experimental Immunology 172 (1), 63-72, 2013 | 71 | 2013 |
| Autoantibodies against type I IFNs in patients with critical influenza pneumonia Q Zhang, A Pizzorno, L Miorin, P Bastard, A Gervais, T Le Voyer, L Bizien, ... Journal of Experimental Medicine 219 (11), e20220514, 2022 | 67 | 2022 |
| A prospective study on the natural history of patients with profound combined immunodeficiency: an interim analysis C Speckmann, S Doerken, A Aiuti, MH Albert, W Al-Herz, LM Allende, ... Journal of Allergy and Clinical Immunology 139 (4), 1302-1310. e4, 2017 | 65 | 2017 |
| Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome JW Leiding, TP Vogel, VGJ Santarlas, R Mhaskar, MR Smith, A Carisey, ... Journal of allergy and clinical immunology 151 (4), 1081-1095, 2023 | 60 | 2023 |
Peter ArkwrightUniversity of Manchester在 manchester.ac.uk 的电子邮件经过验证
Peter ArkwrightUniversity of Manchester在 manchester.ac.uk 的电子邮件经过验证
Gonzalo YebraPublic Health Scotland在 phs.scot 的电子邮件经过验证